<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HEF369C33B36E43B8947484C1C54F2F7B" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 1580 IH: Continuous and Enduring Action to Stop Every Overdose Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-03-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 1580</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20230314">March 14, 2023</action-date>
<action-desc><sponsor name-id="J000299">Mr. Johnson of Louisiana</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.</official-title>
</form>
<legis-body id="H8C26216552E040A380EBD4E0CEC9C6D8" style="OLC">
<section section-type="section-one" id="H8B6F372C006D42579EC008AEB33E04A0"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Continuous and Enduring Action to Stop Every Overdose Act of 2023</short-title></quote> or the <quote><short-title>CEASE Overdose Act of 2023</short-title></quote>. </text></section> <section id="H1F945FE63DDE4BD9AEE5679ACB869406"><enum>2.</enum><header>Class scheduling of fentanyl-related substances</header><text display-inline="no-display-inline">Section 202(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812(c)</external-xref>) is amended by adding at the end of schedule I the following:</text>
<quoted-block style="OLC" id="HE2F46CC806BC4EF685FBD625E4B3E48A">
<subsection id="H6A013415DD8C4036A41FEB3AD62F4BFE"><enum>(e)</enum>
<paragraph commented="no" display-inline="yes-display-inline" id="H618995DD19DE47CDA2749D41CAD5FA54"><enum>(1)</enum><text display-inline="yes-display-inline">Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a fentanyl-related substance, or which contains the salts, isomers, and salts of isomers of a fentanyl-related substance whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.</text></paragraph> <paragraph id="H059AE4F200C94C63B8972F68C87CEDB0" indent="up1"><enum>(2)</enum><text>For purposes of paragraph (1), except as provided in paragraph (3), the term <term>fentanyl-related substance</term> means any substance that is structurally related to fentanyl by 1 or more of the following modifications:</text>
<subparagraph id="H908F6EAA86D94376ACE4D8EED566F34E"><enum>(A)</enum><text>By replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle.</text></subparagraph> <subparagraph id="HDBD094B8CC8C42529806ACBB33550BF0"><enum>(B)</enum><text>By substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups.</text></subparagraph>
<subparagraph id="H0E4FC3F8295E4D9685585758EED7DE7B"><enum>(C)</enum><text>By substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups.</text></subparagraph> <subparagraph id="HB661E08316764CDF9C3160A90B35D0F3"><enum>(D)</enum><text>By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle.</text></subparagraph>
<subparagraph id="H62F4C4AAC28E4B7591A60CF522BD9268"><enum>(E)</enum><text>By replacement of the N-propionyl group with another acyl group.</text></subparagraph></paragraph> <paragraph commented="no" id="H70F7C6F4551F43AAAB574EC87CB72732" indent="up1"><enum>(3)</enum><text display-inline="yes-display-inline">A substance that satisfies the definition of the term <term>fentanyl-related substance</term> in paragraph (2) shall nonetheless not be treated as a fentanyl-related substance subject to this schedule if the substanceâ€”</text>
<subparagraph commented="no" id="HF7C2D647BA6B4796B6BEF08165BAAFE2"><enum>(A)</enum><text>is controlled by action of the Attorney General under section 201; or</text></subparagraph> <subparagraph commented="no" id="H73C44924386B40E19428A3729BFB5E49"><enum>(B)</enum><text>is otherwise expressly listed in a schedule other than this schedule.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section>
</legis-body>
</bill> 


